glutathione variegate porphyria Typical Skin Disease in Cutanea Tarda and Porphyria mRNA-based therapy in a rabbit
mRNA based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks: Molecular Therapy Nucleic Acids The management of porphyria cutanea tarda Sarkany 2001 Clinical and Experimental Dermatology Wiley Online Library Homozygous Variegate Porphyria Porphyria for Professionals Reduced PPOX Expression Causes Intrinsic Pathogenicity in Keratinocytes, Contributing to the Cutaneous Variegate Porphyria Phenotype ScienceDirect
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



